Syndesi Therapeutics, created in 2018 (United States), from 110 sister brands and 17477 competing brands. Syndesi Therapeutics is owned by ABBVIE INC., listed on the stock exchange of New York Syndesi Therapeutics belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ABBVIE INC.
(Syndesi Therapeutics)
over 5 years*
USD 345.25